![6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide](https://static.cymitquimica.com/products/3D/img/FC102246.png "Haga clic para ampliar")
6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
CAS: 585543-15-3
Ref. 3D-FC102246
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- Losmapimod
- 3-Pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-
- 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)nicotinamide
- 6-[5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide
- Gsk-Ahab
- Gw 856553
- Gw 856553X
- Gw856553
- Sb 856553
6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide is a drug that inhibits cancer cell growth by inhibiting the production of natriuretic peptide levels. It also has been shown to be effective in preventing brain infarction and cardiac effects induced by an arterial occlusion. This drug has been shown to have a high risk of side effects, including weight gain, reduced heart rate, increased blood pressure, and increased cholesterol levels. 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide also has the potential to interact with other drugs that are metabolized through the liver enzyme CYP 3A4 (such as simvastatin), which
Propiedades químicas
Consulta técnica sobre: 3D-FC102246 6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
